Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of a corticosteroid (a class of anti-inflammatory drugs) and normal saline (0.9% sodium chloride solution). This mixture is not a single branded or proprietary product but rather a compounded preparation used in various clinical settings. Corticosteroids act by suppressing inflammation and modulating immune responses through glucocorticoid receptor activation, while normal saline serves as an isotonic diluent or vehicle for drug delivery. The combination is commonly used for local injections (e.g., intra-articular, intralesional), nasal irrigations in chronic sinusitis, or as part of other procedures where dilution or volume expansion is needed[2][6]. The specific corticosteroid used can vary (e.g., triamcinolone acetonide, methylprednisolone), depending on the indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corticosteroid + normal saline.